Patient Journey in Advanced Gynecologic Cancers

Launched by TONGJI HOSPITAL · Jun 4, 2025

Keywords

ClinConnect Summary

This clinical trial, titled "Patient Journey in Advanced Gynecologic Cancers," is designed to better understand the experiences of women diagnosed with advanced cervical or endometrial cancer. The study aims to explore how patients make treatment decisions, what their experiences are during treatment, and what needs they may have after treatment is completed. This research is important because it can help improve support for women navigating their cancer journey.

To be eligible for this study, participants must be women aged 18 or older who have recently been diagnosed with stage III or IV cervical or endometrial cancer. They should have finished their initial treatment, which must include chemotherapy or radiotherapy, within the last six months and have been told by their doctor that their disease is stable. Participants will need to sign a consent form to join the study. If you are interested in this research, it could be a valuable opportunity to share your experiences and help others in similar situations.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Age 18 or older
• • Newly diagnosed stage III or IV CC or EC
• • Completed their initial conventional therapies which must include at least chemotherapy, radiotherapy or a combination between Dec. 2022 to Dec. 2024 and the therapies were within 6 months after diagnosis.
• • Told by their physician that their disease is stable.
• • Patients must have informed consent form (ICF) signed for the study.
• Exclusion Criteria:
• • Previously treated with targeted biologic therapy anti-PD-1, anti-PD-L1, or anti PD-L2 agent or with an agent directed to another stimulatory or co-inhibitory T-cell receptor.
• • Previously participated in or participating in a clinical trial.
• • Patients who received another line of therapy after initial therapy.
• • Unable or unwilling to provide informed consent.
• • Not fluent in local language.
• • Indicates or exhibits hearing difficulties, which would make a conversation challenging.